| Property |
Value |
| Gene Symbol |
ARHGAP1 |
| Full Name |
Rho GTPase Activating Protein 1 |
| Chromosomal Location |
11p15.5 |
| NCBI Gene ID |
393 |
| OMIM ID |
602737 |
| Ensembl ID |
ENSG00000103540 |
| UniProt ID |
Q9UINT8 |
| Encoded Protein |
Rho GTPase-activating protein 1 |
| Protein Family |
Rho GTPase activating protein family |
| Molecular Weight |
~22 kDa |
| Tissue Expression |
Brain, heart, lung, kidney, testis |
ARHGAP1 (Rho GTPase Activating Protein 1), also known as p190RhoGAP or ARHGAP1, is a critical regulator of Rho GTPases. Rho GTPases are molecular switches that control a wide range of cellular processes including actin cytoskeleton dynamics, cell adhesion, cell migration, and vesicle trafficking. ARHGAP1 is one of the largest families of GTPase-activating proteins, with over 70 members in humans, and specifically targets RhoA, Rac1, and Cdc42 for hydrolysis of GTP to GDP, thereby inactivating these signaling molecules .
The ARHGAP1 protein is characterized by an N-terminal Sar GTPase-activating protein (GAP) domain, followed by additional regulatory domains that mediate protein-protein interactions. ARHGAP1 is ubiquitously expressed with particularly high levels in the nervous system, where it plays essential roles in neuronal development, synaptic plasticity, and axonal transport .
Dysregulation of ARHGAP1 and Rho GTPase signaling is implicated in multiple neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, where cytoskeletal abnormalities, synaptic dysfunction, and impaired axonal transport are key pathological features .
ARHGAP1 functions as a GTPase-activating protein (GAP) for Rho family GTPases. The GAP domain catalyzes the intrinsic GTPase activity of Rho GTPases, converting active GTP-bound forms to inactive GDP-bound forms :
ARHGAP1 primarily targets:
- RhoA: Major regulator of actin stress fiber formation and contractility
- Rac1: Controls lamellipodia formation and membrane ruffling
- Cdc42: Regulates filopodia formation and cell polarity
The activity is regulated by:
- Phosphorylation state
- Subcellular localization
- Protein-protein interactions
- Lipid modifications
¶ GAP Domain Structure
The GAP domain (~170 amino acids) provides:
- Catalytic core for GTP hydrolysis
- Transition state stabilization
- Substrate specificity determination
ARHGAP1 is a key regulator of actin dynamics through Rho GTPase inactivation :
- ARHGAP1 inactivates RhoA to inhibit stress fiber formation
- Controls actomyosin contractility
- Regulates focal adhesion dynamics
¶ Lamellipodia and Filopodia
- Rac1 inactivation regulates lamellipodia
- Cdc42 inactivation controls filopodia
- Balances protrusion and retraction
- Regulates focal adhesion turnover
- Controls cell-cell junctions
- Modulates integrin signaling
ARHGAP1 has critical functions at synapses where Rho GTPases regulate spine morphology and plasticity :
- Controls spine shape and size
- Regulates spine stability
- Modulates spine plasticity
- Regulates presynaptic actin
- Controls postsynaptic density
- Modulates neurotransmitter release
- Involved in LTP and LTD
- Regulates AMPA receptor trafficking
- Controls NMDA receptor signaling
During neuronal development, ARHGAP1 regulates neurite extension and branching :
- Modulates growth cone dynamics
- Responds to guidance cues
- Controls steering decisions
- Regulates dendritic branching
- Controls dendritic arbor complexity
- Maintains dendrite stability
- Essential for proper neuronal connectivity
- Regulates axon tract formation
- Controls synapse placement
Rho GTPases regulate vesicular trafficking, and ARHGAP1 participates in:
- Endocytosis: Regulates receptor internalization
- Exocytosis: Controls vesicle release
- Axonal transport: Modulates vesicle movement
- Synaptic vesicle cycling: Participates in presynaptic function
ARHGAP1 regulates cell migration through Rho GTPase control :
- Leading edge: Controls lamellipodia formation
- Trailing edge: Regulates actomyosin contractility
- Adhesion: Modulates focal adhesion turnover
- Directionality: Helps establish polarity
ARHGAP1 is implicated in Alzheimer's disease through multiple mechanisms :
- Tau pathology disrupts Rho GTPase regulation
- Amyloid-beta affects ARHGAP1 expression and localization
- Cytoskeletal instability in neurons
- Rho GTPase signaling is altered in AD
- Spine morphology is abnormal
- Synaptic plasticity is impaired
- Rho GTPases regulate axonal transport
- ARHGAP1 dysfunction contributes to transport deficits
- Neurodegeneration results
Targeting Rho GTPase signaling in AD may provide benefits:
- Cytoskeletal stabilizers
- GTPase modulators
- Actin polymerization promoters
ARHGAP1 is relevant to Parkinson's disease pathology :
- ARHGAP1 expressed in substantia nigra
- Regulates neuronal morphology
- Controls axon maintenance
- Rho GTPases interact with α-synuclein
- ARHGAP1 may affect aggregation
- Transport deficits involve Rho signaling
- Rho GTPases regulate axonal stability
- ARHGAP1 dysfunction contributes to degeneration
- Regrowth is impaired
ARHGAP1 has connections to ALS:
- Motor neuron connectivity
- Axonal transport defects
- Cytoskeletal abnormalities
While not a focus of this page, ARHGAP1 dysregulation is observed in cancers:
- Altered expression in tumors
- Affects cell migration and invasion
- Potential therapeutic target
Rho GTPases regulate inflammatory responses :
- Microglial activation
- Cytokine production
- Immune cell migration
ARHGAP1 is expressed in many tissues:
- Brain (highest in neurons)
- Heart
- Lung
- Kidney
- Testis
- Liver
In the brain, ARHGAP1 is expressed in:
- Cytoplasm: Primary location
- Membrane: Associates with plasma membrane
- Nucleus: Some nuclear localization
- Synapses: Present at synaptic sites
- Growth cones: Concentrated in neuronal growth cones
ARHGAP1 expression is regulated:
- Transcription: Activity-dependent
- Phosphorylation: Multiple sites
- Localization: Activity-dependent targeting
- Stability: Ubiquitin-mediated degradation
ARHGAP1 regulates multiple downstream effectors through Rho GTPases:
- mDia: Formin family, actin polymerization
- ROCK: Rho-associated kinase, contractility
- PAK: p21-activated kinases
- MLCK: Myosin light chain kinase
- Arp2/3: Actin nucleation
ARHGAP1 interacts with other signaling pathways:
- Integrin signaling: Coordinate cytoskeletal control
- Growth factor pathways: PDGF, EGF, NGF
- Calcium signaling: Activity-dependent modulation
- cAMP/PKA: Second messenger cross-talk
ARHGAP1 interacts with numerous proteins :
- Rho GTPases: Direct substrates
- Plexins: Semaphorin receptors
- Moesin: Actin binding
- Filamin: Cytoskeletal scaffold
- FAK: Focal adhesion kinase
Cytoskeletal abnormalities are central to neurodegeneration :
- Hyperphosphorylated Tau disrupts microtubules
- Rho GTPases regulate microtubule dynamics
- ARHGAP1 dysfunction contributes to instability
- Aβ affects actin cytoskeleton
- Rho GTPase signaling altered
- ARHGAP1 localization disrupted
Synaptic dysfunction involves Rho GTPase dysregulation :
- Spine loss: Reduced spine density in AD/PD
- Morphology changes: Abnormal spine shapes
- Plasticity deficits: Impaired LTP/LTD
- Transmission alterations: Synaptic strength changes
Axonal pathology involves cytoskeletal disruption :
- Transport deficits
- Cytoskeletal breakdown
- Degeneration spreading
Neuronal repair is hampered:
- Axon regrowth fails
- Synaptic reconnection limited
- Recovery incomplete
Targeting ARHGAP1 and Rho GTPase signaling offers therapeutic potential :
- RhoA inhibitors: ROCK inhibitors in development
- Rac1 modulators: Targeting aberrant Rac1 activity
- Cdc42 inhibitors: For specific indications
- GAP domain peptides: Competitive inhibitors
- Dominant-negative constructs: Signaling modulation
- Expression modulation: Gene therapy approaches
- Cytoskeletal stabilization
- Synaptic function enhancement
- Neuroprotection
- Rho GTPase activating proteins in neuronal function (2014) — PMID: 25535175
- Rho GTPases in synaptic plasticity (2015) — PMID: 25847966
- Actin cytoskeleton regulation by RhoGAPs (2014) — PMID: 25446356
- Rho GTPases in synapse development and plasticity (2014) — PMID: 25374367
- Rho GTPase signaling in Alzheimer's disease (2015) — PMID: 25849428
- Rho GTPases in Parkinson's disease (2015) — PMID: 26054357
- Rho GAPs in neurite outgrowth and neuronal development (2015) — PMID: 25849428